SNP&SEQ

Job opportunity
 Although we are currently not advertising for any open job positions at the SNP&SEQ Technology Platform you are welcome to send a spontaneous application (CV + personal letter) to:
ann-christine.syvanen@medsci.uu.se.
 We are constantly looking for experienced and skilled research engineers and bioinformaticians.

 

Head of the SNP&SEQ Technology Platform
and Research group leader:
 Prof. Ann-Christine Syvänen
Email: Ann-Christine.Syvanen@medsci.uu.se
Phone: +46 (0) 18 611 29 59
Mobile: +46 (0) 70 167 94 45

 

SNP-Genotyping inquiries:
 Tomas Axelsson, PhD, Manager - SNP-genotyping
Email: Tomas.Axelsson@medsci.uu.se
Phone: +46 (0) 18 611 26 44
Mobile: +46 (0) 70 167 94 58

 

Illumina sequencing inquiries:
 Olof Karlberg, PhD, Manager - Illiumina sequencing
Email: seq@medsci.uu.se
Phone: +46 (0) 18 611 49 34
Mobile: +46 (0) 70 167 94 42

 

454 sequencing inquiries:
 Kristina Larsson, Manager - 454 sequencing
Email: seq@medsci.uu.se
Phone: +46 (0) 18 611 49 34
Mobile: +46 (0) 70 167 94 51

 

 


Address:   The SNP&SEQ Technology Platform
                Uppsala University Hospital
                Entr. 70, 3rd floor, Res. Dept. 2, lab. 20
                751 85 Uppsala
                Sweden

 

The SNP&SEQ Technology Platform at Uppsala University, Uppsala Sweden is located in the Research Department 2 & 3 at the Uppsala University Hospital, Entrance 70, 3rd floor.

(Click image to enlarge)

 Find on

 

News

  • MolMed receives new grant

    2012-04-23

    Large grant for epigenetic and genomic analyses of the brain from VR, FAS, Formas and Vinnova to Molecular Medicine and the SNP&SEQ platform.

  • New sequencer, MiSeq

    2012-03-16

    The SNP&SEQ Technology Platform has installed a MiSeq instrument from Illumina.

  • The Swedish Childhood Cancer Foundation

    2011-12-14

    Molecular Medicine research group has received funding from the Swedish Childhood Cancer Foundation.

  • VR grant

    2011-11-17

    VR-RFI has granted 6.7 million SEK for running costs to the SNP&SEQ platform.

  • K&A Wallenberg grant

    2011-10-04

    Molecular Medicine research group has received funding from the K&A Wallenberg foundation.

  • Publication in Nature

    2011-08-11

    A study that doubles the number of susceptibility genes for multiple sclerosis (MS) was published in Nature on Aug 11.

  • Instrument Upgrade.

    2011-06-20

    The SNP&SEQ Technology Platform have now upgraded our Genome Analyzer IIx with a HiSeq 2000 instrument from Illumina.

  • Publication in Nature Genetics

    2011-03-06

    Five new loci for coronary artery disease were published on-line in Nature Genetics on March 6th.

  • European Project: ESGI

    2011-01-18

    The Molecular Medicine group contributes to the ESGI infra-structure by technology development, eg. allele-specific gene expression and epigenetics.